Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 5Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Observational 4Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 6392Neoplasms 5365Prostatic Neoplasms 2966Carcinoma, Non-Small-Cell Lung 2709Colorectal Neoplasms 2679Lung Neoplasms 2267Multiple Myeloma 1663Lymphoma 1600Neoplasm Metastasis 1552Leukemia, Myeloid, Acute 1540Melanoma 1486Pancreatic Neoplasms 1470Ovarian Neoplasms 1423Leukemia 1389Head and Neck Neoplasms 1284Precursor Cell Lymphoblastic Leukemia-Lymphoma 1282Lymphoma, Non-Hodgkin 1231Colonic Neoplasms 1159Carcinoma, Hepatocellular 1142Stomach Neoplasms 1129Leukemia, Lymphocytic, Chronic, B-Cell 1090Brain Neoplasms 1050Rectal Neoplasms 980Lymphoma, Follicular 979Recurrence 976Uterine Cervical Neoplasms 926Glioblastoma 920Carcinoma, Renal Cell 882Lymphoma, Large B-Cell, Diffuse 853Hodgkin Disease 777

Interventions

Denosumab 2Curettage 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Giant Cell Tumors × Clear all
NCT06331104 2024-04-02

Network Pharmacology Prediction: Mechanism Study of Puerarin in the Treatment of Giant Cell Tumors of Bone

First Affiliated Hospital, Sun Yat-Sen University

Completed
145 enrolled

Giant Cell Tumors

NCT05542524 2023-12-13

DENO

University Hospital, Strasbourg, France

Completed
12 enrolled

Giant Cell Tumors

NCT02948088 2023-10-31

TOP

Daiichi Sankyo

Completed
183 enrolled 26 charts

Giant Cell Tumors, Synovitis, Pigmented Villonodular

NCT00680992 2022-09-22

Study of Denosumab in Subjects With Giant Cell Tumor of Bone

Amgen

Phase 2 Completed
535 enrolled 16 charts

Giant Cell Tumors, Neoplasms, Giant Cell Tumor of Bone

NCT02996734 2016-12-22

GCTLIMBS

Istituto Ortopedico Rizzoli

Completed
412 enrolled
Sarcoma

Bone Neoplasms, Giant Cell Tumors, Giant Cell Tumor of Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡